Submit Deal

MLS CAPITAL FUND II

Summary

MLS Capital Fund II (MLSCF II), co-managed by Spruce Capital Partners and Xeraya Capital, invests the funds in a diversified portfolio of biogreentech companies at all stages of development.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 948 M

Avg. Deal Size£ 474 M

Market Context

Sort

16 Jun 2020|United States|Biotechnology

Target: GREENLIGHT BIOSCIENCES INC

Bidder: MLS CAPITAL FUND II

11 Service Providers

1 Target | 10 Bidder

12 Dealmakers

1 Target | 11 Bidder

£ 81 M

Value

10 Aug 2021|United States|Biotechnology

Target: GREENLIGHT BIOSCIENCES INC

Bidder: XERAYA CAPITAL

17 Service Providers

4 Target | 13 Bidder

39 Dealmakers

5 Target | 34 Bidder

£ 866 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy